| scholarly article | Q13442814 |
| P50 | author | Vincenzo Cirigliano | Q57043796 |
| Antoni Borrell | Q49101519 | ||
| P2093 | author name string | M Grande | |
| J Cid | |||
| E Grau | |||
| J L Marin | |||
| E Ordoñez | |||
| A Pericot | |||
| I Teixido | |||
| P2860 | cites work | Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women. | Q50792929 |
| Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis. | Q53597278 | ||
| Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy. | Q54301772 | ||
| Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation. | Q54393922 | ||
| The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. | Q54520641 | ||
| Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. | Q54574187 | ||
| The D category VI type 4 allele is prevalent in the Spanish population. | Q54610689 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Management of Rhesus Alloimmunization in Pregnancy | Q22242754 | ||
| RHD positive haplotypes in D negative Europeans | Q24801894 | ||
| Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma | Q28314918 | ||
| Molecular background of VS and weak C expression in blacks | Q29354127 | ||
| Fetal sex determination using circulating cell-free fetal DNA (ccffDNA) at 11 to 13 weeks of gestation | Q33664901 | ||
| Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women | Q33917070 | ||
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
| Restriction enzyme-mediated enhanced detection of circulating cell-free fetal DNA in maternal plasma | Q35069908 | ||
| Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study | Q36538133 | ||
| Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service | Q40626763 | ||
| The VS and V blood group polymorphisms in Africans: a serologic and molecular analysis | Q46160746 | ||
| Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD. | Q47808590 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | genotyping | Q912147 |
| P304 | page(s) | 173-178 | |
| P577 | publication date | 2012-12-20 | |
| P1433 | published in | Prenatal Diagnosis | Q15760059 |
| P1476 | title | Clinical application of midtrimester non-invasive fetal RHD genotyping and identification of RHD variants in a mixed-ethnic population | |
| P478 | volume | 33 |
| Q51823244 | Determination of Fetal RHD Genotype Including the RHD Pseudogene in Maternal Plasma. |
| Q43599210 | Evaluation of sample stability and automated DNA extraction for fetal sex determination using cell-free fetal DNA in maternal plasma |
| Q64243238 | High-throughput, non-invasive prenatal testing for fetal rhesus D status in RhD-negative women: a systematic review and meta-analysis |
| Q38178923 | Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care |
| Q87466211 | Noninvasive fetal RhD genotyping |
| Q54088983 | Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis. |
| Q28071888 | Recent advances in prenatal genetic screening and testing |
Search more.